Psychostimulant-related health service demand in an inner-city hospital, 2012-2015

Public Health Res Pract. 2018 Mar 15;28(1):28011800. doi: 10.17061/phrp28011800.

Abstract

Objective: To analyse routinely collected data from a hospital database of drug health consultation-liaison (CL) assessments. We aimed to investigate changes in psychostimulant-related health service demand in an inner-city hospital to inform the development of locally appropriate models of care.

Methods: We used de-identified drug health CL service data from 2012 to 2015. Psychostimulant-related consultations and admissions were compared with opioid-related consultations and admissions over time, by sex and by ward type (medical units, mental health units or emergency department).

Results: The CL service collected information on 8800 consultations and 4405 hospital admissions from 2012 to 2015. Psychostimulant use was responsible for 684 (7.8%) consultations and 372 (8.4%) admissions. Opioids were related to 1914 (21.8%) consultations and 864 (19.6%) admissions. Psychostimulants were the subject of three times more consultations in 2015 than in 2012, and more than twice as many admissions. Time trend analysis showed a significant time effect for consultations and admissions relating to psychostimulants. Conversely, no significant changes were observed in consultations and admissions relating to opioids.

Conclusion: This study identified a rapid rise in the demand for psychostimulant-related inpatient assessments, suggesting the use of these drugs has increased locally. Because of the impact on the public health system, there is a need to invest in and implement new treatment strategies and services for psychostimulant users.

MeSH terms

  • Admitting Department, Hospital / statistics & numerical data*
  • Adult
  • Australia
  • Emergency Service, Hospital / statistics & numerical data*
  • Female
  • Hospitals, Urban / statistics & numerical data*
  • Humans
  • Male
  • Mental Disorders / diagnosis*
  • Mental Disorders / drug therapy*
  • Middle Aged
  • Narcotics / therapeutic use*
  • Patients / statistics & numerical data*

Substances

  • Narcotics